Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
British Journal of Cancer
|
March 31, 2021
Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer
Alexander Semaan, Vincent Bernard, Dong U Kim, et al.
Annals of Surgical Oncology
|
April 9, 2020
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer
Giampaolo Perri, Laura Prakash, Giuseppe Malleo, et al.
Cancer
|
July 8, 2011
Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation
Jeannelyn S Estrella, Asif Rashid, Jason B Fleming, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2021
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary
Kanwal Raghav, Hyunsoo Hwang, Alexandre A Jácome, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2008
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head
Douglas B Evans, Gauri R Varadhachary, Christopher H Crane, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 15, 2016
Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation
Sunil Krishnan, Awalpreet S Chadha, Yelin Suh, et al.
Annals of Surgical Oncology
|
October 17, 2018
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Pat Gulhati, Laura Prakash, Matthew H G Katz, et al.
Annals of Surgical Oncology
|
February 18, 2010
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation
Matthew H G Katz, Gauri R Varadhachary, Jason B Fleming, et al.
Annals of Surgical Oncology
|
February 12, 2013
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma
Daniel E Abbott, Ching-Wei David Tzeng, Ryan P Merkow, et al.
Cancers
|
December 9, 2020
Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study
Mohamed Zaid, Lauren Widmann, Annie Dai, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
British Journal of Cancer
|
March 31, 2021
Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer
Alexander Semaan, Vincent Bernard, Dong U Kim, et al.
Annals of Surgical Oncology
|
April 9, 2020
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer
Giampaolo Perri, Laura Prakash, Giuseppe Malleo, et al.
Cancer
|
July 8, 2011
Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation
Jeannelyn S Estrella, Asif Rashid, Jason B Fleming, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2021
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary
Kanwal Raghav, Hyunsoo Hwang, Alexandre A Jácome, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2008
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head
Douglas B Evans, Gauri R Varadhachary, Christopher H Crane, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 15, 2016
Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation
Sunil Krishnan, Awalpreet S Chadha, Yelin Suh, et al.
Annals of Surgical Oncology
|
October 17, 2018
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Pat Gulhati, Laura Prakash, Matthew H G Katz, et al.
Annals of Surgical Oncology
|
February 18, 2010
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation
Matthew H G Katz, Gauri R Varadhachary, Jason B Fleming, et al.
Annals of Surgical Oncology
|
February 12, 2013
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma
Daniel E Abbott, Ching-Wei David Tzeng, Ryan P Merkow, et al.
Cancers
|
December 9, 2020
Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study
Mohamed Zaid, Lauren Widmann, Annie Dai, et al.
Page
of 12